{"transactions":[{"id":834210,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:30:18.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":5310,"price":0.19,"value":1008.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,800 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":572179,"source":{"system":"sec-edgar","filing":"0001477932-26-001488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001488/form4.xml","form_type":"4"}},{"id":878852,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:30:44.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":149000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 149,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":577489,"source":{"system":"sec-edgar","filing":"0001477932-26-001096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001096/form4.xml","form_type":"4"}},{"id":932897,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:10.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":35400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 118,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 35,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 82,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":428489,"source":{"system":"sec-edgar","filing":"0001477932-26-000362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000362/form4.xml","form_type":"4"}},{"id":1022726,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:15.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5850,"price":0.648,"value":3790.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":393089,"source":{"system":"sec-edgar","filing":"0001477932-25-007400","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007400/form4.xml","form_type":"4"}},{"id":1031001,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-09-30T20:01:49.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5568,"price":0.605,"value":3368.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,375 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":398939,"source":{"system":"sec-edgar","filing":"0001477932-25-007231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007231/form4.xml","form_type":"4"}},{"id":1126730,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:05:44.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":21526,"price":0.503,"value":10827.578,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 47,837 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":404507,"source":{"system":"sec-edgar","filing":"0001477932-25-004365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004365/form4.xml","form_type":"4"}},{"id":1144410,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-19T17:23:05.000Z","date":"2025-05-19","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.43,"value":21500.0,"ownership":{"direct":true},"balance_after":426033,"source":{"system":"sec-edgar","filing":"0001477932-25-003965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225003965/form4.xml","form_type":"4"}},{"id":1160385,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-05T20:05:08.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":18319,"price":0.4875,"value":8930.5125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 40,709 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":376033,"source":{"system":"sec-edgar","filing":"0001477932-25-003314","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225003314/form4.xml","form_type":"4"}},{"id":1290360,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-31T21:05:18.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."}],"balance_after":50000,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-25-000610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225000610/form4.xml","form_type":"4"}},{"id":1290359,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-31T21:05:18.000Z","date":"2025-01-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-25-000610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225000610/form4.xml","form_type":"4"}},{"id":1338316,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-10T21:01:16.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":43691,"price":0.5722,"value":24999.9902,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx."}],"balance_after":394352,"source":{"system":"sec-edgar","filing":"0001477932-24-007970","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007970/form4.xml","form_type":"4"}},{"id":1389751,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-10-08T20:01:10.000Z","date":"2024-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5200,"price":0.883,"value":4591.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":350661,"source":{"system":"sec-edgar","filing":"0001477932-24-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224006281/form4.xml","form_type":"4"}},{"id":1397618,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-10-01T20:06:21.000Z","date":"2024-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4950,"price":0.578,"value":2861.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,375 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":355861,"source":{"system":"sec-edgar","filing":"0001477932-24-006101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224006101/form4.xml","form_type":"4"}},{"id":1417086,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-04T20:04:34.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":47837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 1, 2024, the reporting person was awarded 47,837 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 15,946 units, 15,946 units, and 15,945 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":360811,"source":{"system":"sec-edgar","filing":"0001477932-24-005506","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005506/form4.xml","form_type":"4"}},{"id":1432056,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-08-16T20:05:42.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On Sept 28, 2023, the reporting person was awarded 55,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 13,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 4,583 units, 4,583 units, and 4,584 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 23,375 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 17,875 RSUs did not vest and were cancelled on August 15, 2024."}],"balance_after":312974,"source":{"system":"sec-edgar","filing":"0001477932-24-005025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005025/form4.xml","form_type":"4"}},{"id":1494254,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:06:05.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":40709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2024, the reporting person was awarded 40,709 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 13,570 units, 13,570 units, and 13,569 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":299224,"source":{"system":"sec-edgar","filing":"0001477932-24-003484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003484/form4.xml","form_type":"4"}},{"id":1670365,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-26T21:04:59.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":23375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 28, 2023, the reporting person was awarded 55,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 23,375 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 7,792 units, 7,792 units, and 7,791 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":258515,"source":{"system":"sec-edgar","filing":"0001477932-24-000413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224000413/form4.xml","form_type":"4"}},{"id":1792614,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-31T13:35:31.000Z","date":"2023-08-30","kind":"purchase","planned":false,"acquired":true,"shares":8750,"price":1.27,"value":11112.5,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001477932-23-006539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223006539/form4.xml","form_type":"4"}},{"id":1792613,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-31T13:35:31.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":11250,"price":1.24,"value":13950.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":46250,"source":{"system":"sec-edgar","filing":"0001477932-23-006539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223006539/form4.xml","form_type":"4"}},{"id":1795864,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-28T14:07:26.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.24,"value":24800.0,"ownership":{"direct":true},"balance_after":235140,"source":{"system":"sec-edgar","filing":"0001477932-23-006497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223006497/form4.xml","form_type":"4"}},{"id":1814402,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-07T20:05:20.000Z","date":"2023-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5427,"price":1.3,"value":7055.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,062 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":215140,"source":{"system":"sec-edgar","filing":"0001477932-23-005788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223005788/form4.xml","form_type":"4"}},{"id":1833373,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-07-07T20:01:20.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":17550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 39,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,550 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 5,850 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 6,825 RSUs and 14,625 RSUs subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":220567,"source":{"system":"sec-edgar","filing":"0001477932-23-005109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223005109/form4.xml","form_type":"4"}},{"id":2055277,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-13T21:02:29.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 14,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in October 2022, the rights with respect to 6,825 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":203017,"source":{"system":"sec-edgar","filing":"0001477932-23-000268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223000268/form4.xml","form_type":"4"}},{"id":2080552,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-12-20T15:04:17.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":25000,"price":2.3,"value":57500.0,"ownership":{"direct":true},"balance_after":188392,"source":{"system":"sec-edgar","filing":"0001477932-22-009423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222009423/form4.xml","form_type":"4"}},{"id":2080551,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-12-20T15:04:17.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":7339,"price":1.96,"value":14384.44,"ownership":{"direct":true},"balance_after":163392,"source":{"system":"sec-edgar","filing":"0001477932-22-009423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222009423/form4.xml","form_type":"4"}},{"id":2137419,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-10-14T20:02:52.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":6825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 6,825 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 2,275 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":156053,"source":{"system":"sec-edgar","filing":"0001477932-22-007693","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007693/form4.xml","form_type":"4"}},{"id":2154539,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-09-20T13:47:38.000Z","date":"2022-09-19","kind":"purchase","acquired":true,"shares":13000,"price":1.7,"value":22100.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001477932-22-007051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007051/form4.xml","form_type":"4"}},{"id":2171287,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-30T14:14:23.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":29000,"price":1.74,"value":50460.0,"ownership":{"direct":true},"balance_after":149228,"source":{"system":"sec-edgar","filing":"0001477932-22-006505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222006505/form4.xml","form_type":"4"}},{"id":2194105,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-05T20:01:58.000Z","date":"2022-08-03","kind":"tax_withholding","acquired":false,"shares":4825,"price":1.97,"value":9505.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,063 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction"}],"balance_after":120228,"source":{"system":"sec-edgar","filing":"0001477932-22-005692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222005692/form4.xml","form_type":"4"}},{"id":2222600,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:03:49.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":28898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 44,457 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 28,898 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 14,450 shares and 14,448 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 15,559 shares subject to the award previously vested and remain subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 44,457 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 28,898 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 14,450 shares and 14,448 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 15,559 shares subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":44457,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":28898},"source":{"system":"sec-edgar","filing":"0001477932-22-004661","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004661/form4.xml","form_type":"4"}},{"id":2222599,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-06-24T20:03:49.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":15682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 24,125 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 15,682 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 7,842 units and 7,840 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in April 2022, the rights with respect to the remaining 8,443 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":125053,"source":{"system":"sec-edgar","filing":"0001477932-22-004661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004661/form4.xml","form_type":"4"}},{"id":2300891,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:04:23.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":15559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 44,457 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 15,559 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 7,779 shares and 7,780 shares on each of August 3, 2022 and August 3, 2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 44,457 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 15,559 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 7,779 shares and 7,780 shares on each of August 3, 2022 and August 3, 2023, respectively."}],"balance_after":15559,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":15559},"source":{"system":"sec-edgar","filing":"0001477932-22-002183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002183/form4.xml","form_type":"4"}},{"id":2300890,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-08T20:04:23.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":8443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 24,125 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 8,443 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 4,221 units and 4,222 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":109371,"source":{"system":"sec-edgar","filing":"0001477932-22-002183","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002183/form4.xml","form_type":"4"}},{"id":2524061,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:08.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."}],"balance_after":75000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001477932-21-007867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007867/form4.xml","form_type":"4"}},{"id":2524060,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:08.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001477932-21-007867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007867/form4.xml","form_type":"4"}},{"id":2524059,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:08.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":3467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."}],"balance_after":3467,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":3467},"source":{"system":"sec-edgar","filing":"0001477932-21-007867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007867/form4.xml","form_type":"4"}},{"id":2524058,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:08.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":3467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":3467},"source":{"system":"sec-edgar","filing":"0001477932-21-007867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007867/form4.xml","form_type":"4"}},{"id":2524057,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:08.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 15, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 15, 2026 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 15, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 15, 2026 (ten years from the original date of grant)."}],"balance_after":125000,"derivative":{"exercise_price":4,"exercise_date":"2017-04-15","expiration_date":"2026-04-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001477932-21-007867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007867/form4.xml","form_type":"4"}},{"id":2524056,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:08.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 15, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 15, 2026 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 15, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 15, 2026 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2017-04-15","expiration_date":"2022-04-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001477932-21-007867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007867/form4.xml","form_type":"4"}},{"id":2561357,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2021-09-23T20:44:03.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The \"old\" options were originally granted on April 13, 2020 and vested in full at 12 months from the date of grant, and were exercisable until April 13, 2026. The \"replacement\" options are fully-vested on the date of grant and have an expiration date of April 13, 2030."}],"balance_after":70000,"derivative":{"exercise_price":3.6,"exercise_date":"2021-09-21","expiration_date":"2030-04-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001477932-21-006595","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221006595/form4.xml","form_type":"4"}},{"id":2561356,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2021-09-23T20:44:03.000Z","date":"2020-04-13","kind":"disposition_to_issuer","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The \"old\" options were originally granted on April 13, 2020 and vested in full at 12 months from the date of grant, and were exercisable until April 13, 2026. The \"replacement\" options are fully-vested on the date of grant and have an expiration date of April 13, 2030."}],"balance_after":0,"derivative":{"exercise_price":3.6,"exercise_date":"2021-04-13","expiration_date":"2026-04-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001477932-21-006595","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221006595/form4.xml","form_type":"4"}},{"id":2561355,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2021-09-23T20:44:03.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":66533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The \"old\" options were originally granted on December 16, 2019, vested in full on the date of grant, and were exercisable until March 30, 2023. The \"replacement\" options are fully-vested on the date of grant and have an expiration date of March 30, 2027."}],"balance_after":66533,"derivative":{"exercise_price":5,"exercise_date":"2021-09-21","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":66533},"source":{"system":"sec-edgar","filing":"0001477932-21-006595","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221006595/form4.xml","form_type":"4"}},{"id":2561354,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2021-09-23T20:44:03.000Z","date":"2019-12-16","kind":"disposition_to_issuer","acquired":false,"shares":66533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The \"old\" options were originally granted on December 16, 2019, vested in full on the date of grant, and were exercisable until March 30, 2023. The \"replacement\" options are fully-vested on the date of grant and have an expiration date of March 30, 2027."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2019-12-16","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":66533},"source":{"system":"sec-edgar","filing":"0001477932-21-006595","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221006595/form4.xml","form_type":"4"}},{"id":2632754,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T20:55:37.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old' options and the grant of \"replacement\" options.  The \"old\" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable.  The \"replacement\" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old' options and the grant of \"replacement\" options.  The \"old\" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable.  The \"replacement\" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant)."}],"balance_after":55000,"derivative":{"exercise_price":4,"exercise_date":"2016-01-23","expiration_date":"2025-07-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-21-000678","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878221000678/primary_doc.xml","form_type":"4"}},{"id":2632753,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T20:55:37.000Z","date":"2021-07-14","kind":"disposition_to_issuer","acquired":false,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old' options and the grant of \"replacement\" options.  The \"old\" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable.  The \"replacement\" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old' options and the grant of \"replacement\" options.  The \"old\" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable.  The \"replacement\" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2016-01-23","expiration_date":"2021-07-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-21-000678","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878221000678/primary_doc.xml","form_type":"4"}},{"id":2933950,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:18:37.000Z","date":"2020-12-22","kind":"gift","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 125,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Dr. Micallef on April 15, 2016 under the Issuer's 2015 Stock Incentive Plan and transferred to Borlaug Limited (\"Borlaug\"), a consulting firm, on April 20, 2016.  Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option.  The option was then transferred by Borlaug to Dr. Micallef on December 22, 2020."}],"balance_after":125000,"derivative":{"exercise_price":4,"exercise_date":"2017-04-15","expiration_date":"2022-04-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001078782-20-001006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220001006/primary_doc.xml","form_type":"4"}},{"id":2933949,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:18:37.000Z","date":"2020-12-22","kind":"gift","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 125,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Dr. Micallef on April 15, 2016 under the Issuer's 2015 Stock Incentive Plan and transferred to Borlaug Limited (\"Borlaug\"), a consulting firm, on April 20, 2016.  Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option.  The option was then transferred by Borlaug to Dr. Micallef on December 22, 2020."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2017-04-15","expiration_date":"2022-04-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001078782-20-001006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220001006/primary_doc.xml","form_type":"4"}},{"id":3061217,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-12T19:28:55.000Z","date":"2020-08-10","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2016-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-20-000610","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000610/primary_doc.xml","form_type":"4"}},{"id":3061216,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-12T19:28:55.000Z","date":"2020-08-10","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2015-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-20-000610","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000610/primary_doc.xml","form_type":"4"}},{"id":3061215,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-12T19:28:55.000Z","date":"2020-08-10","kind":"tax_withholding","acquired":false,"shares":60080,"price":3.5,"value":210280.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person.  No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction."}],"balance_after":100928,"source":{"system":"sec-edgar","filing":"0001078782-20-000610","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000610/primary_doc.xml","form_type":"4"}},{"id":3061214,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-12T19:28:55.000Z","date":"2020-08-10","kind":"exercise","acquired":true,"shares":65000,"price":3,"value":195000.0,"ownership":{"direct":true},"balance_after":161008,"source":{"system":"sec-edgar","filing":"0001078782-20-000610","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000610/primary_doc.xml","form_type":"4"}},{"id":3061213,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-12T19:28:55.000Z","date":"2020-08-10","kind":"tax_withholding","acquired":false,"shares":55158,"price":3.5,"value":193053.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person.  No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction."}],"balance_after":96008,"source":{"system":"sec-edgar","filing":"0001078782-20-000610","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000610/primary_doc.xml","form_type":"4"}},{"id":3061212,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-12T19:28:55.000Z","date":"2020-08-10","kind":"exercise","acquired":true,"shares":65000,"price":2.5,"value":162500.0,"ownership":{"direct":true},"balance_after":151166,"source":{"system":"sec-edgar","filing":"0001078782-20-000610","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000610/primary_doc.xml","form_type":"4"}},{"id":3075393,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-07-28T14:32:22.000Z","date":"2020-07-27","kind":"gift","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option to purchase 55,000 shares of Common Stock of the Issuer was granted to Borlaug on July 23, 2015 under the Issuer's 2011 Plan.  The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020."}],"balance_after":55000,"derivative":{"exercise_price":4,"exercise_date":"2016-01-23","expiration_date":"2021-07-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-20-000565","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000565/primary_doc.xml","form_type":"4"}},{"id":3075392,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-07-28T14:32:22.000Z","date":"2020-07-27","kind":"gift","acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option to purchase 55,000 shares of Common Stock of the Issuer was granted to Borlaug on July 23, 2015 under the Issuer's 2011 Plan.  The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2016-01-23","expiration_date":"2021-07-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-20-000565","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000565/primary_doc.xml","form_type":"4"}},{"id":3075391,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-07-28T14:32:22.000Z","date":"2020-07-27","kind":"gift","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Borlaug Limited (\"Borlaug\"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the \"2011 Plan\").  Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option.  The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020."}],"balance_after":65000,"derivative":{"exercise_price":3,"exercise_date":"2016-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-20-000565","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000565/primary_doc.xml","form_type":"4"}},{"id":3075390,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-07-28T14:32:22.000Z","date":"2020-07-27","kind":"gift","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Borlaug Limited (\"Borlaug\"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the \"2011 Plan\").  Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option.  The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020."}],"balance_after":65000,"derivative":{"exercise_price":2.5,"exercise_date":"2015-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-20-000565","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000565/primary_doc.xml","form_type":"4"}},{"id":3075389,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-07-28T14:32:22.000Z","date":"2020-07-27","kind":"gift","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Borlaug Limited (\"Borlaug\"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the \"2011 Plan\").  Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option.  The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020."}],"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2016-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-20-000565","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000565/primary_doc.xml","form_type":"4"}},{"id":3075388,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-07-28T14:32:22.000Z","date":"2020-07-27","kind":"gift","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the \"Issuer\"), was granted to Borlaug Limited (\"Borlaug\"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the \"2011 Plan\").  Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option.  The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020."}],"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2015-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-20-000565","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000565/primary_doc.xml","form_type":"4"}},{"id":3177005,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-15T20:57:21.000Z","date":"2020-04-13","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 70,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":70000,"derivative":{"exercise_price":3.6,"exercise_date":"2021-04-13","expiration_date":"2026-04-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001078782-20-000262","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000262/primary_doc.xml","form_type":"4"}},{"id":3337900,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2019-12-18T16:39:27.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":66533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person.  The \"old\" options were originally granted on March 30, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested on the date of grant and have the same expiration date and exercise price as the \"old\" options."}],"balance_after":70000,"derivative":{"exercise_price":5,"exercise_date":"2019-12-16","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":66533},"source":{"system":"sec-edgar","filing":"0001078782-19-000924","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000924/primary_doc.xml","form_type":"4"}},{"id":3337899,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2019-12-18T16:39:27.000Z","date":"2019-12-16","kind":"disposition_to_issuer","acquired":false,"shares":66533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person.  The \"old\" options were originally granted on March 30, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested on the date of grant and have the same expiration date and exercise price as the \"old\" options."}],"balance_after":3467,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001078782-19-000924","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000924/primary_doc.xml","form_type":"4"}},{"id":3630537,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2019-02-27T21:27:01.000Z","date":"2019-02-25","kind":"other","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person's wife exercised a warrant to purchase 11,000 shares of Common Stock of the issuer for $2.20 per share.  The warrant was set to expire pursuant to its terms on February 26, 2019."}],"balance_after":0,"derivative":{"exercise_price":2.2,"exercise_date":"2014-02-26","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001078782-19-000187","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000187/primary_doc.xml","form_type":"4"}},{"id":3630536,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-02-27T21:27:01.000Z","date":"2019-02-25","kind":"other","acquired":true,"shares":11000,"price":2.2,"value":24200.0,"ownership":{"direct":false,"nature":"By Wife"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person's wife exercised a warrant to purchase 11,000 shares of Common Stock of the issuer for $2.20 per share.  The warrant was set to expire pursuant to its terms on February 26, 2019."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001078782-19-000187","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000187/primary_doc.xml","form_type":"4"}},{"id":3662021,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T21:40:05.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 50,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001078782-19-000132","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000132/primary_doc.xml","form_type":"4"}},{"id":3722976,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2018-12-21T22:24:15.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on July 23, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These options to purchase Common Stock are owned of record by Borlaug Limited, which is a consulting firm.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of these options.  However, Dr. Micallef disclaims beneficial ownership of these options and the Common Stock issuable upon exercise of the options except to the extent of his pecuniary interest therein."}],"balance_after":55000,"derivative":{"exercise_price":4,"exercise_date":"2016-01-23","expiration_date":"2021-07-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-18-001451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218001451/primary_doc.xml","form_type":"4"}},{"id":3722975,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2018-12-21T22:24:15.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on July 23, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These options to purchase Common Stock are owned of record by Borlaug Limited, which is a consulting firm.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of these options.  However, Dr. Micallef disclaims beneficial ownership of these options and the Common Stock issuable upon exercise of the options except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2016-01-23","expiration_date":"2020-01-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-18-001451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218001451/primary_doc.xml","form_type":"4"}},{"id":3722974,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2018-12-21T22:24:15.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable.  The \"replacement\" options are fully-vested and both installments expire on August 18, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These options to purchase Common Stock are owned of record by Borlaug Limited, which is a consulting firm.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of these options.  However, Dr. Micallef disclaims beneficial ownership of these options and the Common Stock issuable upon exercise of the options except to the extent of his pecuniary interest therein."}],"balance_after":65000,"derivative":{"exercise_price":3,"exercise_date":"2016-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-18-001451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218001451/primary_doc.xml","form_type":"4"}},{"id":3722973,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2018-12-21T22:24:15.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable.  The \"replacement\" options are fully-vested and both installments expire on August 18, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These options to purchase Common Stock are owned of record by Borlaug Limited, which is a consulting firm.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of these options.  However, Dr. Micallef disclaims beneficial ownership of these options and the Common Stock issuable upon exercise of the options except to the extent of his pecuniary interest therein."}],"balance_after":65000,"derivative":{"exercise_price":2.5,"exercise_date":"2015-02-18","expiration_date":"2020-08-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-18-001451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218001451/primary_doc.xml","form_type":"4"}},{"id":3722972,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2018-12-21T22:24:15.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable.  The \"replacement\" options are fully-vested and both installments expire on August 18, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These options to purchase Common Stock are owned of record by Borlaug Limited, which is a consulting firm.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of these options.  However, Dr. Micallef disclaims beneficial ownership of these options and the Common Stock issuable upon exercise of the options except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2016-02-18","expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-18-001451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218001451/primary_doc.xml","form_type":"4"}},{"id":3722971,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (Right to Buy)","published_at":"2018-12-21T22:24:15.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable.  The \"replacement\" options are fully-vested and both installments expire on August 18, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These options to purchase Common Stock are owned of record by Borlaug Limited, which is a consulting firm.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of these options.  However, Dr. Micallef disclaims beneficial ownership of these options and the Common Stock issuable upon exercise of the options except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2015-02-18","expiration_date":"2019-02-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001078782-18-001451","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218001451/primary_doc.xml","form_type":"4"}},{"id":4090530,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-25T22:28:59.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 75,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001078782-18-000074","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218000074/primary_doc.xml","form_type":"4"}},{"id":4366210,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-03T20:13:55.000Z","date":"2017-03-30","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 70,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":70000,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001078782-17-000407","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878217000407/primary_doc.xml","form_type":"4"}},{"id":4377216,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2017-03-21T20:18:17.000Z","date":"2017-03-17","kind":"sale","acquired":false,"shares":5000,"price":2000,"value":10000000.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Warrant is held directly by Borlaug Limited.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Warrant.  Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Warrant, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":2.6,"exercise_date":"2012-05-11","expiration_date":"2017-05-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001078782-17-000337","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878217000337/primary_doc.xml","form_type":"4"}},{"id":4548117,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-21T21:20:39.000Z","date":"2016-11-18","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Option is held directly by Borlaug Limited.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Option.  Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Option, except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2012-11-25","expiration_date":"2016-11-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001078782-16-003844","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878216003844/primary_doc.xml","form_type":"4"}},{"id":4548116,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-21T21:20:39.000Z","date":"2016-11-18","kind":"tax_withholding","acquired":false,"shares":13393,"price":4.48,"value":60000.64,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise.  No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of Common Stock are held directly by Borlaug Limited.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issued to Borlaug Limited upon the exercise of the Option.  Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issued upon exercise of the Option, except to the extent of his pecuniary interest."}],"balance_after":38113,"source":{"system":"sec-edgar","filing":"0001078782-16-003844","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878216003844/primary_doc.xml","form_type":"4"}},{"id":4548115,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":57269,"kind":"person","name":"Micallef Jacob Vincent","position":1,"cik":"0001651671","reported_name":"Micallef Jacob Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-21T21:20:39.000Z","date":"2016-11-18","kind":"exercise","acquired":true,"shares":20000,"price":3,"value":60000.0,"ownership":{"direct":false,"nature":"Borlaug Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of Common Stock are held directly by Borlaug Limited.  Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issued to Borlaug Limited upon the exercise of the Option.  Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issued upon exercise of the Option, except to the extent of his pecuniary interest."}],"balance_after":51506,"source":{"system":"sec-edgar","filing":"0001078782-16-003844","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878216003844/primary_doc.xml","form_type":"4"}}]}